Abstract
Background: Hydrolethalus Syndrome 1 (HYDS1) is a rare disorder that occurs commonly in Finnish infants but originates from the mother. This autosomal recessive syndrome is associated with the FBF1, which is usually expressed in the centriole. The FBF1 is an inheritable arthritis disease phenotype that includes rheumatoid arthritis. Several studies have investigated males with FBF1 mutation carriers also related to arthritis diseases, including those under rheumatoid arthritis conditions, which revealed the possibility of conferring the gene mutation to the next generation of offspring. Nonetheless, there are some complications of FBF1 mutation with target miRNAs that can be affected by exercise.
Objective: The objective of this study was to evaluate the different exercises that can be utilized to suppress the FBF1 mutation targeted by Novel-rno-miRNAs-1135 as a biomarker and assess the effectiveness of exercise in mitigating the FBF1 mutation.
Methods: Four exercise interventional groups were divided into exercise and non-exercise groups. One hundred microliter pristane-induced arthritis (PIA) was injected at the dorsal region of the tails of rodents and introduced to the two PIA interventional groups. On day fortyfive, all animals were euthanized, and total RNA was extracted from the blood samples of rodents, while polymerase chain reaction (PCR) was amplified by using 5-7 primers. Computerization was used for miRNA regulation and analysis of target gene candidates.
Results: The novel-rno-miRNA-1135 was downregulated to FBF1 in exercise groups. The exercise was found to have no significant impact in terms of change in novel-rno-miRNA-1135 regulation of FBF1 expression.
Conclusion: Exercise has no impact on novel-rno-miRNA-1135 targeted for FBF1 in autosomal recessive disease.
Keywords: Novel, miRNA, exercise, hydrolethalus syndrome, rheumatoid arthritis, autosomal.
[http://dx.doi.org/10.1097/NEN.0b013e318180ec2e] [PMID: 18648327]
[http://dx.doi.org/10.1097/00019605-200101000-00011] [PMID: 11152149]
[http://dx.doi.org/10.1002/(SICI)1097-0223(199903)19:3<279::AID-PD518>3.0.CO;2-L] [PMID: 10210131]
[http://dx.doi.org/10.3389/fcell.2019.00381] [PMID: 31998723]
[http://dx.doi.org/10.1086/302603] [PMID: 10486328]
[http://dx.doi.org/10.1038/nrg2361] [PMID: 18427557]
[http://dx.doi.org/10.1073/pnas.1401464112]
[http://dx.doi.org/10.1016/j.devcel.2004.09.013] [PMID: 15525531]
[http://dx.doi.org/10.1016/j.ajpath.2017.08.031] [PMID: 29030052]
[http://dx.doi.org/10.1016/j.ceb.2015.04.015] [PMID: 25988548]
[http://dx.doi.org/10.1038/ncomms3750] [PMID: 24231678]
[http://dx.doi.org/10.1093/genetics/iyaa006] [PMID: 33683352]
[http://dx.doi.org/10.1007/s00438-013-0734-z] [PMID: 23334784]
[http://dx.doi.org/10.1002/ajmg.1320270421] [PMID: 3321994]
[http://dx.doi.org/10.3390/life10050058] [PMID: 32403239]
[http://dx.doi.org/10.1038/s41574-020-0377-1] [PMID: 32632275]
[http://dx.doi.org/10.1016/j.autrev.2012.06.007] [PMID: 22776785]
[http://dx.doi.org/10.1016/j.pcad.2017.06.003] [PMID: 28666746]
[http://dx.doi.org/10.1186/s13063-023-07588-3] [PMID: 37814321]
[http://dx.doi.org/10.1002/bimj.202200061] [PMID: 36071025]
[http://dx.doi.org/10.1007/978-1-59745-402-5_19] [PMID: 17983154]
[http://dx.doi.org/10.1093/bioinformatics/btu170] [PMID: 24695404]
[http://dx.doi.org/10.1093/nar/gky1141] [PMID: 30423142]
[http://dx.doi.org/10.1093/nar/gkr688] [PMID: 21911355]
[http://dx.doi.org/10.3389/fcell.2020.00301]
[http://dx.doi.org/10.3390/jcdd5010007] [PMID: 29370121]
[http://dx.doi.org/10.1159/000452507] [PMID: 27832652]
[http://dx.doi.org/10.1186/1472-6793-13-9] [PMID: 24219008]
[http://dx.doi.org/10.1042/CS20100043]
[http://dx.doi.org/10.1126/sciadv.abd7605] [PMID: 33568480]
[PMID: 34792705]
[http://dx.doi.org/10.1016/B978-032305475-1.50031-8]
[http://dx.doi.org/10.1016/B978-012340440-4/50051-9]
[http://dx.doi.org/10.1016/0092-8674(94)90331-X] [PMID: 8293461]